Previous close | 1.7900 |
Open | 1.7000 |
Bid | 1.7400 x 1400 |
Ask | 1.7500 x 1200 |
Day's range | 1.6500 - 1.7799 |
52-week range | 0.9900 - 1.9950 |
Volume | |
Avg. volume | 318,058 |
Market cap | 93.194M |
Beta (5Y monthly) | 0.55 |
PE ratio (TTM) | 4.02 |
EPS (TTM) | 0.4300 |
Earnings date | 09 May 2024 - 13 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 7.50 |
It's been a good week for Spero Therapeutics, Inc. ( NASDAQ:SPRO ) shareholders, because the company has just released...
Spero Therapeutics, Inc. (NASDAQ:SPRO) Q4 2023 Earnings Call Transcript March 13, 2024 Spero Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.96, expectations were $-0.1. SPRO isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon and welcome to the […]
Most readers would already be aware that Spero Therapeutics' (NASDAQ:SPRO) stock increased significantly by 35% over...